List of Topotarget UK Limited patents

Patents where

Current Assignee

Name

‌

Topotarget UK Limited

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7465719 Carbamic acid compounds comprising an ester or ketone linkage as HDAC inhibitors	Patent 7465719 was granted and assigned to Topotarget UK Limited on December, 2008 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7465719	December 16, 2008
‌ US Patent 7880020 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors	Patent 7880020 was granted and assigned to Topotarget UK Limited on February, 2011 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7880020	February 1, 2011
‌ US Patent 7557140 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors	Patent 7557140 was granted and assigned to Topotarget UK Limited on July, 2009 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7557140	July 7, 2009
‌ US Patent 7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors	Patent 7183298 was granted and assigned to Topotarget UK Limited on February, 2007 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7183298	February 27, 2007
‌ US Patent 7407988 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors	Patent 7407988 was granted and assigned to Topotarget UK Limited on August, 2008 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7407988	August 5, 2008
‌ US Patent 7569724 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors	Patent 7569724 was granted and assigned to Topotarget UK Limited on August, 2009 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7569724	August 4, 2009
‌ US Patent 7160677 Transcription factor DP-1	Patent 7160677 was granted and assigned to Topotarget UK Limited on January, 2007 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7160677	January 9, 2007
‌ US Patent 7981895 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors	Patent 7981895 was granted and assigned to Topotarget UK Limited on July, 2011 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7981895	July 19, 2011
‌ US Patent 9603926 Histone deacetylase (HDAC) inhibitors for the treatment of cancer	Patent 9603926 was granted and assigned to Topotarget UK Limited on March, 2017 by the United States Patent and Trademark Office.	‌ Topotarget UK Limited	‌ Topotarget UK Limited	United States Patent and Trademark Office	9603926	March 28, 2017
‌ US Patent 10285959 Combination therapies using HDAC inhibitors	Patent 10285959 was granted and assigned to Topotarget UK Limited on May, 2019 by the United States Patent and Trademark Office.	‌ Topotarget UK Limited	‌ Topotarget UK Limited	United States Patent and Trademark Office	10285959	May 14, 2019
‌ US Patent 8071620 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors	Patent 8071620 was granted and assigned to Topotarget UK Limited on December, 2011 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	8071620	December 6, 2011
‌ US Patent 9980957 Histone deacetylase (HDAC) inhibitors for the treatment of cancer	Patent 9980957 was granted and assigned to Topotarget UK Limited on May, 2018 by the United States Patent and Trademark Office.	‌ Topotarget UK Limited	‌ Topotarget UK Limited	United States Patent and Trademark Office	9980957	May 29, 2018
‌ US Patent 9957227 Pharmaceutical formulations of HDAC inhibitors	Patent 9957227 was granted and assigned to Topotarget UK Limited on May, 2018 by the United States Patent and Trademark Office.	‌ Topotarget UK Limited	‌ Topotarget UK Limited	United States Patent and Trademark Office	9957227	May 1, 2018
‌ US Patent 8835501 Pharmaceutical formulations of HDAC inhibitors	Patent 8835501 was granted and assigned to Topotarget UK Limited on September, 2014 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	8835501	September 16, 2014
‌ US Patent 7652036 Carbamic acid compounds comprising a bicyclic heteroaryl group as HDAC inhibitors	Patent 7652036 was granted and assigned to Topotarget UK Limited on January, 2010 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7652036	January 26, 2010
‌ US Patent 8828392 Histone deacetylase (HDAC) inhibitors (PXD101) for the treatment of cancer alone or in combination with chemotherapeutic agent	Patent 8828392 was granted and assigned to Topotarget UK Limited on September, 2014 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	8828392	September 9, 2014
‌ US Patent 9856211 Pharmaceutical formulations of HDAC inhibitors	Patent 9856211 was granted and assigned to Topotarget UK Limited on January, 2018 by the United States Patent and Trademark Office.	‌ Topotarget UK Limited	‌ Topotarget UK Limited	United States Patent and Trademark Office	9856211	January 2, 2018
‌ US Patent 7629343 Carbamic acid compounds comprising a piperazine linkage as HDAC inhibitors	Patent 7629343 was granted and assigned to Topotarget UK Limited on December, 2009 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7629343	December 8, 2009
‌ US Patent 10799469 Combination therapies using HDAC inhibitors		‌ Topotarget UK Limited	‌ Topotarget UK Limited	United States Patent and Trademark Office	10799469	October 13, 2020
‌ US Patent 8642809 Methods of synthesis of certain hydroxamic acid compounds	Patent 8642809 was granted and assigned to Topotarget UK Limited on February, 2014 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	8642809	February 4, 2014
‌ US Patent 7012128 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays	Patent 7012128 was granted and assigned to Topotarget UK Limited on March, 2006 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	7012128	March 14, 2006
‌ US Patent 6841385 Transcription factor E2F DNA-binding domain inhibitor peptides and their use	Patent 6841385 was granted and assigned to Topotarget UK Limited on January, 2005 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	6841385	January 11, 2005
‌ US Patent 6960685 Carbamic acid compounds comprising an ether linkage as HDAC inhibitors	Patent 6960685 was granted and assigned to Topotarget UK Limited on November, 2005 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	6960685	November 1, 2005
‌ US Patent 6888027 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors	Patent 6888027 was granted and assigned to Topotarget UK Limited on May, 2005 by the United States Patent and Trademark Office.		‌ Topotarget UK Limited	United States Patent and Trademark Office	6888027	May 3, 2005

24 results

0 selected

24 results

0 selected